Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Stem Cells Market to Advance at CAGR of 10.4% During 2021-2028, Says TMR

This image opens in the lightbox

News provided by

Transparency Market Research

31 Mar, 2022, 13:30 GMT

Share this article

Share toX

Share this article

Share toX

  • Autologous stem-cell-based gene therapy underpins massive revenue potential; advancements in stem cell banking services to support next-gen therapies
  • Massive funding for stem cell research in North America propelling substantial revenue potential in stem cells market

ALBANY, N.Y., March 31, 2022 /PRNewswire/ -- Expanding research on stem cells biologics has opened several new frontiers in the treatment of neurological disorders, cancer, heart diseases, and diabetes. Increasing utilization of stem cell culturing media and advancements in harvesting methods have expanded the potential applications of stem cells. The stem cells market is projected to reach valuation of US$ 25.68 Bn by 2028.

Growing number of clinical studies in stem cell-based regenerative medicine are creating value-grab opportunities for pharmaceutical companies, assert the analysts in the TMR study on the stem cells market. Advancements in multipotent haematopoietic stem cell (HSC) transplantation have extended the avenue. Characterization of human embryonic stem cells is enriching the value chain of the stem cells market, since they have emerged as a promising source of regenerative medicine.

Request Brochure of Stem Cells Market Research Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=132 

Autologous stem-cell-based gene therapies hold promise for inherited disorders. These are gaining preference over allogeneic stem cell transplantation in some blood-specific diseases.

Key Findings of Stem Cells Market Study

  • Companies Harnessing Stem Cells in Regenerative Medicine for Numerous Diseases: The potential of stem cells in regenerative medicine has expanded considerably, pivoting on the back of a growing array of preclinical and clinical therapies. Human embryonic stem cells and induced pluripotent stem cells are proved to be promising candidate for therapeutic use in regenerative medicine in various diseases. Cardiovascular regenerative therapies are a case in point. The regenerative medicines segment held a leading share of the global stem cells market in 2020, finds the authors of the TMR study.

Request for Analysis of COVID-19 Impact on Stem Cells Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=132 

  • Growing Government Funding for Stem Cell Research Spurs Growth: Therapeutics companies have benefitted from the rise in R&D by governments in stem cell research. This has also enriched stem cell banking infrastructure. The demand for stem cell therapies for hematological disorders has been offering lucrative opportunities, concurs the analysts in the stem cells market. A case in point is growing R&D in autologous stem cell-based gene therapies for primary immunodeficiencies (PIDs), congenital forms of cytopenia, and hemoglobinopathies. Gene editing technologies are pivoting the expansion of avenues in the stem cells market.

Stem Cells Market: Key Drivers

  • The growing morbidity of chronic diseases is a key driver for strides in stem cell therapies. In particular, the prevalence of cardiovascular disease has been extending the avenue for biotech and pharmaceutical companies in the stem cells market.
  • Advancements in manufacturing standards and culture systems ae propelling the prospects of the stem cells market. Of note, expanding stem cell biology, including the exploration of reliable sources of these cells, and harvesting technologies hope for untreatable diseases.

Stem Cells Market: Regional Growth Dynamics

  • North America held a major share of the global stem cells market in 2020, and is projected to retain its lead during the forecast period. Extensive research funding by governments and private players on regenerative medicine especially for chronic diseases has spurred revenue gains in the regional market.
  • The Asia Pacific stem cells market is estimated to expand at a remarkable growth rate during the forecast period. The growing research spending of pharmaceutical companies on stem cell-based therapies for malignant and non-malignant diseases has bolstered lucrative possibilities, note the in-depth TMR study.

Get Exclusive PDF Sample Copy of Stem Cells Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=132

Stem Cells Market: Key Players

Some of the key players in the stem cells market are Caladrius Biosciences, Inc., Osiris Therapeutics, Inc., Cytori Therapeutics, Inc., U.S. Stem Cell, Inc., Takara Bio, Inc., BioTime, Inc., Cellular Engineering Technologies, Inc., and Astellas Pharma, Inc.

Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=132 

Global Stem Cells Market: Segmentation

Stem Cells Market, by Product

  • Adult Stem Cell
  • Human Embryonic Stem Cell
  • Induced Pluripotent Stem Cell
  • Others

Stem Cells Market, by Source

  • Autologous
  • Allogenic

Stem Cells Market, by Application

  • Regenerative Medicines
    • Neurology
    • Oncology
    • Cardiology
    • Others
  • Drug Discovery & Development

Stem Cells Market, by End-user

  • Therapeutics Companies
  • Cell & Tissue Banks
  • Tools & Reagents Companies
  • Service Companies

Stem Cells Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Rest of Middle East & Africa

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Industry Research Reports by Transparency Market Research:

Human Embryonic Stem Cells Market: The stem cell therapy has garnered immense popularity and is rapidly emerging as one of the most promising areas of research. Recent developments pertaining to the stem cell treatment have paved the way for a plethora of potential therapies due to which, treatments related to human embryonic stem cells are gaining widespread adoption worldwide.

Cancer Stem Cells Market: The rising shift in oncology therapeutics from conventional therapies such as surgeries, chemotherapy, and radiotherapy to stem cell therapies points at expansive growth cancer stem cells market over the 2020 – 2030 forecast period. Over the past couple of years, stem cells have found valuable use for replacement of blood after tumor formation or after tumor treatment.

Synthetic Stem Cells Market: Various types of adult stems cells in regenerative medicines have generated considerable attention and interest among clinicians and the industries at large. There have been a groundswell of interest in stem cell-targeted therapies in cardiology and neurology among researchers. However, the vast therapeutic benefits these have still lack substantial scientific evidence and consistent clinical backing.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Follow Us: Twitter | LinkedIn
Blog: https://tmrblog.com
Browse PR - https://www.transparencymarketresearch.com/pressrelease/stem-cells-market.htm 

Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg 

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.